期刊
CELL
卷 136, 期 1, 页码 26-36出版社
CELL PRESS
DOI: 10.1016/j.cell.2008.12.027
关键词
-
资金
- National Institutes of Health
- European Union, through MUGEN
- Cancer Research Institute
- Joint Program in Hematology and Transfusion Medicine at Harvard Medical School
MicroRNA (miRNA) control has emerged as a critical regulatory principle in the mammalian immune system. Genetic ablation of the miRNA machinery, as well as loss or deregulation of certain individual miRNAs, severely compromises immune development and response and can lead to immune disorders like autoimmunity and cancer. Although individual miRNAs modulate protein output from hundreds of target genes, they may impact physiological processes by regulating the concentrations of just a few key cellular proteins that may be components of a single or of functionally interrelated pathways in a given cellular context.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据